title: Clinical Inquiry: Do venlafaxine and gabapentin control hot flashes in women with a history of breast cancer?
abstract: Venlafaxine reduces hot flashes more than placebo in women with a history of breast cancer; adverse effects include dry mouth and constipation.
authors: Valley Family Medicine Residency, Renton, WA, USA.
authors: Angela
authors: A
authors: Sarkissian
authors: Jon O
authors: JO
authors: Neher
authors: Ravipal
authors: R
authors: Singh
authors: Leilani
authors: L
authors: St Anna
mesh_terms: D000588:Amines / Q000008:administration & dosage / Q000009:adverse effects; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000009:adverse effects; D001943:Breast Neoplasms / Q000150:complications*; D003248:Constipation / Q000139:chemically induced; D003509:Cyclohexanecarboxylic Acids / Q000008:administration & dosage / Q000009:adverse effects; D003511:Cyclohexanols / Q000008:administration & dosage / Q000009:adverse effects; D004244:Dizziness / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D005260:Female; D000077206:Gabapentin; D019584:Hot Flashes / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D056687:Off-Label Use; D016032:Randomized Controlled Trials as Topic; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D012720:Severity of Illness Index; D016896:Treatment Outcome; D000069470:Venlafaxine Hydrochloride; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D000588:Amines; D014151:Anti-Anxiety Agents; D003509:Cyclohexanecarboxylic Acids; D003511:Cyclohexanols; D000077206:Gabapentin; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride; D005680:gamma-Aminobutyric Acid